08. Is dronedarone currently available to treat patients?

Dronedarone has been approved under the brand name Multaq® by the US Food and Drug Administration on July 1, 2009 and by Health Canada on August 12, 2009. A registration dossier is currently under regulatory review by the European Medicines Agency (EMEA).